New Delhi [India], January 30 (ANI): As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay
Jaipur (Rajasthan) [India], January 29 (ANI): Rajasthan Minister Mahesh Joshi on Saturday called the Alwar rape case a "complicated matter" in which a specially-abled girl was found lying in a distressed condition.
New Delhi [India], January 28 (ANI): The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.
Beijing [China], January 27 (ANI): Moderna, an American pharmaceutical and biotechnology company based in Cambridge on Wednesday (local time) announced that it has begun clinical trials of a booster dose of a vaccine designed specifically to combat the Omicron variant of COVID-19.
Beijing [China], January 24 (ANI): As the villages for the Beijing Winter Olympic opened for pre-Games trials on Sunday, a Chinese state media report slammed the US on the issue of the Olympic boycott being staged by several countries over human rights issues in China.
Cambridge (England) [UK], January 21 (ANI): A study has warned that promising new education interventions have been potentially 'unnecessarily scrapped' because trials to test their effectiveness may be insufficiently faithful to the original research.
Mumbai (Maharashtra) [India], January 18 (ANI): The third round of 19th Asian Games equestrian (show jumping) trials for the team and the individual event concluded at Amateur Riders' Club, Mahalaxmi Race Course in Maharashtra.
Mumbai (Maharashtra) [India], January 11 (ANI): The third round of 19th Asian Games equestrian (show jumping) trials for the selections will take place from January 12 to 16 at the Amateur Riders Club under the aegis of the Equestrian Federation of India (EFI), at Mahalakshmi Race Course, Mu
New Delhi [India], January 8 (ANI): Covaxin manufacture Bharat Biotech on Saturday said that the booster dose trials have shown "promising results" of long-term safety with "no serious adverse events".
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav